Provided by Tiger Trade Technology Pte. Ltd.

Lipella Pharmaceuticals Inc

0.1900
-0.0001-0.05%
Volume:500.00
Turnover:97.00
Market Cap:848.81K
PE:-0.08
High:0.2000
Open:0.2000
Low:0.1900
Close:0.1901
52wk High:4.49
52wk Low:0.1650
Shares:4.47M
Float Shares:4.18M
Volume Ratio:0.05
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2600
EPS(LYR):-4.7857
ROE:-361.77%
ROA:-149.95%
PB:0.57
PE(LYR):-0.04

Loading ...

Company Profile

Company Name:
Lipella Pharmaceuticals Inc
Exchange:
PINK
Establishment Date:
2005
Employees:
6
Office Location:
7800 Susquehanna St.,Suite 505,Pittsburgh,Pennsylvania,United States
Zip Code:
15208
Fax:
- -
Introduction:
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.